- our experts
- Student Sphere
- Hotel & Travel
Personalized therapies are treatments that are tailored to an individual's unique characteristics, such as their genetics, lifestyle, and medical history. The goal of personalized therapies is to provide more effective and targeted treatments that are better suited to the specific needs of each patient. This approach contrasts with traditional "one-size-fits-all" approaches to medicine, which may not take into account individual differences in patients' biology or health status.
In recent years, personalized therapies have gained increasing attention in various fields of medicine, including oncology, cardiology, and neurology. For example, personalized cancer therapies may involve genetic testing to identify specific mutations in a patient's tumor cells, which can help guide the selection of targeted therapies that are more likely to be effective. Similarly, personalized cardiovascular therapies may involve lifestyle modifications, such as dietary changes and exercise programs, in addition to medication and surgical interventions.
Overall, personalized therapies have the potential to improve patient outcomes and reduce healthcare costs by minimizing the use of ineffective treatments and optimizing the use of more targeted interventions. However, personalized therapies also require a significant amount of research and testing to determine the most effective treatment strategies for each patient.
Personalized therapies refer to treatments that are tailored to the individual characteristics of each patient, such as their genetic makeup, disease subtype, or other factors. This approach to treatment aims to improve patient outcomes and reduce adverse events by targeting therapies to the specific needs of each patient.
The global personalized therapies market is expected to grow significantly in the coming years, driven by factors such as increasing demand for personalized healthcare, advancements in genetic sequencing technologies, and the need to reduce healthcare costs by improving treatment outcomes.
According to a report by MarketsandMarkets, the global personalized therapies market size is expected to reach USD 2.4 trillion by 2025, at a compound annual growth rate (CAGR) of 10.5% during the forecast period. The market is segmented based on product, application, and end user.
Based on product, the market is segmented into cell and gene therapies, personalized medical devices, personalized medicines, and personalized nutrition and wellness. The personalized medicines segment dominated the market in 2020, accounting for the largest share of the global personalized therapies market. The segment is driven by the increasing use of genomic testing and other diagnostic tools to identify patients who are likely to benefit from targeted therapies.
Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases, and others. The oncology segment dominated the market in 2020, accounting for the largest share of the global personalized therapies market. The segment is driven by the increasing prevalence of cancer and the need for more effective and personalized therapies.
Based on end user, the market is segmented into hospitals and clinics, diagnostic laboratories, and research institutions. The hospitals and clinics segment dominated the market in 2020, accounting for the largest share of the global personalized therapies market. The segment is driven by the increasing adoption of personalized therapies in hospital and clinic settings.
North America dominated the global personalized therapies market in 2020, followed by Europe and the Asia Pacific. The dominance of North America is attributed to the presence of a large number of pharmaceutical and biotechnology companies, the high healthcare expenditure, and the growing adoption of personalized healthcare in the region.
The key players operating in the global personalized therapies market include Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN N.V., Roche Holding AG, and Novartis AG, among others. These companies are investing heavily in research and development activities to develop targeted therapies and diagnostics for specific patient subpopulations and gain a competitive edge.
Overall, the personalized therapies market is expected to experience significant growth in the coming years, driven by the increasing demand for personalized healthcare, advancements in genetic sequencing technologies, and the need to reduce healthcare costs by improving treatment outcomes.
ALSO READ Drugs and Drug Targets Drug Discovery, Design and Development Pharmacokinetics and Pharmacodynamics Computer Aided Drug Design Drug Metabolism Pharmaceutical Biotechnology Combinatorial Chemistry Novel Drug Delivery Systems Formulations Natural Products Traditional Medicine Drug Repurposing and Drug Repositioning Precision Medicine Personalized Therapies Drug Development and Clinical Trials Biomarker Discovery and Development Biologics and Biosimilars Vaccines and Immunotherapies Steam Cells and Regenerative Medicine Drug Safety and Pharmacovigilance Pharmacogenomics Toxicology Rare Diseases Receptors as Target for Drug Discovery Drugs Affecting the Cardiovascular System Drugs Affecting the Central Nervous System Drugs Affecting Hormonal Systems Chemotherapeutic Agents Antibacterial Agents Antiviral Agents Anticancer Agents The Opioid Analgesics Anti-Ulcer Agents Non-Steroidal Anti Inflammatory Drugs Steroids Antibiotics Antineoplastic Agents Anthelmintics Sulphonamides Artificial Intelligence and Machine Learning in Drug Discovery and Development Genomics and Proteomics in Drug Discovery and Development Gene Therapy and Genome Editing in Treating Genetic Diseases Nanotechnology in Drug Delivery and Imaging Virtual and Augmented Reality in Drug Discovery and Development Patient Engagement and Patient-Centered Drug Development Big Data Analytics in Drug Discovery and Development
Precision Medicine Conferences Drug Design Conferences 2023 Medicinal Chemistry Conferences 2023 USA Medicinal Chemistry Conferences 2023 Europe Medicinal Chemistry Conferences 2023 Canada Traditional Medicine Conferences Pharmacology Conferences Pharmaceutical Chemistry Conferences Drug Discovery Conferences 2023 Natural Products Conferences Combinatorial Chemistry Conferences